drugset / Trial / NCT00314925
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary purpose of the study is to determine if Seneca Valley Virus may be administered safely to patients with certain types of advanced cancer.
Timeline
- Start
- 2006-04
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seneca Valley Virus | Other / unclassified | 1e+07 unknown | Intravenous |